 |
| MAY
19, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
WEEKLY CEO Q&A:
Sean A. McCarthy, CEO & Chairman,
CytomX Therapeutics |
|
In this Q&A, McCarthy reflects on the
origin of CytomX's differentiated
scientific vision, clinical and strategic
milestones that define the company's
progress, what it takes to sustain a
high-performing team through uncertainty,
and why he remains optimistic about the
future of oncology innovation. More |
|
|
 |
The
Most Trusted Contract Vivarium
in Every Bio Hub
Opening in San Diego Fall 2026 |
|
Learn More
→ |
|
|
- Artiva
Biotherapeutics: Appoints Veteran Biotech
Executive and Drug Developer Diego Miralles,
M.D., as President and Head of Research and
Development More
- Aspera
Biomedicines: Successfully Launches Second
ADAR1p150 Crystallization Experiment to the
International Space Station Aboard SpaceX
CRS-34 More
- Belite
Bio: Receives Orphan Drug Status for
Tinlarebant in Stargardt Disease in
Switzerland More
- Biotheryx:
Data From Its Phase 1 Dose Escalation Study of
BTX-9341, a First-in-Class, Potent and
Selective CDK4/6 Degrader, for the Treatment
of Advanced/Metastatic HR+/HER2- Breast Cancer
More
- Neurocrine
Biosciences: Presents Real-World Data
Highlighting Functional Impact of Mild Tardive
Dyskinesia Severity and Improvement With
INGREZZA (valbenazine) Capsules More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Biopharma Therapeutics and Platforms M&A
– Q1 2026 Review More
- More on Design Therapeutics Stock
Wobbling After Rare Genetic Disease Data More
More*
- Neurocrine Biosciences: Completes
Acquisition of Soleno Therapeutics More
|
|
 |
| Biotech’s
most flexible vivarium lab space
to launch and scale studies. |
|
Learn More
→ |
|
|
- Life Science Leader: Business of Biotech –
April Recap More
- Radio-pharmaceuticals Are Changing the
Rules of Cancer Therapy More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Biopharmas Pull Back on Layoffs in Q1 More
- 17 Companies Hiring in California More
- Empowering Students through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- Hiring Outlook: Job Opportunities on
BioSpace Rise YOY, but Layoffs Affect
Thousands More
- How Industry Trends are Impacting Hiring
Decisions and Leadership Strategies in Life
Sciences More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- Novo’s Double Departures: As GLP-1 Luminary
Retires, an Obesity Leader Goes to Boehringer
Ingelheim More*
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- 2026 Q1 Job Market Report: Job Postings
Picked up as Quarter Progressed More
- Telling Your Science Story to Investors More
- Top 10 High-Impact Careers Defining the
Future of Life Sciences More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
